A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System

CompletedOBSERVATIONAL
Enrollment

525

Participants

Timeline

Start Date

September 13, 2017

Primary Completion Date

March 19, 2019

Study Completion Date

March 19, 2019

Conditions
Breast Cancer Female
Interventions
DEVICE

Breast Biopsy

A breast biopsy is a test that removes tissue or sometimes fluid from the suspicious area. The removed cells are examined under a microscope and further tested to check for the presence of breast cancer. A biopsy is a diagnostic procedure that can definitely determine if the suspicious area is cancerous.

Trial Locations (7)

14620

Elizabeth Wende Breast Center, Rochester

15213

Magee-Womens Hospital of UPMC, Pittsburgh

29895

Kensington Medical Center - Kaiser Permanente, Kensington

63110

Washington University, St Louis

77030

MD Anderson Cancer Center, Houston

84112

University of Utah - Huntsman Cancer Hospital, Salt Lake City

85027

HonorHealth, Phoenix

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Hologic, Inc.

INDUSTRY